What it is (overview)

The Anti-Helicobacter pylori (Anti–H. pylori) test is an antibody blood test that checks whether your immune system has made antibodies against Helicobacter pylori (H. pylori), a common type of bacteria that can infect the stomach lining. H. pylori is linked to stomach infection, gastritis (inflammation of the stomach lining), and peptic ulcers (sores in the stomach or upper small intestine). It can contribute to symptoms such as abdominal pain, bloating, nausea, and other GI symptoms.

This test typically measures antibodies such as IgG (and sometimes IgA/IgM, depending on the lab). A positive Anti–H. pylori result means your body has been exposed to H. pylori at some point and has produced antibodies. However, because antibodies can stay in your blood for months or even years, a positive antibody test may not always prove that the infection is currently active.

A negative result usually means there is no evidence of H. pylori antibodies, making a current or past infection less likely. In early infection, antibodies may not have developed yet, and in some people the antibody response can be lower than expected.

Because antibody tests can’t always distinguish between a past and an active infection, clinicians may confirm suspected active H. pylori with tests such as a urea breath test or stool antigen test, especially when deciding on treatment or checking whether treatment worked. Your doctor will interpret your result alongside your symptoms, history, and any other diagnostic test findings.

When & why it's usually done

Your clinician may order an Anti–H. pylori antibody test when you have symptoms or clinical findings that suggest H. pylori–related stomach irritation or ulcer disease. It is often part of an evaluation for ongoing upper digestive discomfort and can help guide next steps in diagnosis and treatment.

Common reasons this diagnostic test may be ordered include:

Ongoing upper GI symptoms such as:

• Burning or gnawing abdominal pain (often in the upper abdomen)
• Indigestion/dyspepsia, fullness, early satiety
• Bloating, burping, nausea, or decreased appetite
• Symptoms that come and go or worsen when the stomach is empty

Concern for ulcers or complications, including:

• Suspected peptic ulcer (stomach or duodenal ulcer)
• History of ulcers or ulcer bleeding
• Unexplained iron-deficiency anemia or low vitamin B12 in some cases (your clinician will determine appropriateness)

Gastritis evaluation:

• Suspected gastritis (stomach lining inflammation) based on symptoms or other tests

When other tests aren’t available or appropriate:

• In some settings, antibody testing may be used when stool or breath testing is not easily accessible. Because it may stay positive after past infection, your clinician may prefer a stool antigen or breath test to confirm an active H. pylori bacterial infection and to verify eradication after treatment.

Important note: If you have warning signs such as vomiting blood, black/tarry stools, severe or persistent pain, trouble swallowing, unexplained weight loss, or anemia, urgent medical evaluation is recommended. These symptoms may require endoscopy and additional testing beyond an antibody test.

Common diseases related to it

• Helicobacter pylori (H. pylori) stomach infection
• Gastritis (including chronic active gastritis)
• Peptic ulcer disease (gastric ulcer and duodenal ulcer)
• Dyspepsia (indigestion-related upper abdominal discomfort)
• Upper gastrointestinal bleeding related to ulcers (in some cases)

Health goals where it may help

• Supporting digestive health by evaluating causes of persistent upper GI symptoms
• Helping identify a possible infectious cause of abdominal pain, indigestion, or suspected ulcers
• Guiding next steps for diagnosis (e.g., deciding whether confirmatory testing such as stool antigen or urea breath testing is needed)
• Informing treatment planning for suspected H. pylori–related gastritis or ulcer disease
• Supporting overall gastrointestinal wellness by addressing potential stomach lining inflammation and reducing recurrence risk when combined with appropriate follow-up testing